Form 4: Phreesia Director Ramin Sayar Granted 6,700 Restricted Stock Units

Phreesia, Inc. Director Ramin Sayar was granted 6,700 Restricted Stock Units (RSUs) valued at $27.61 per share, increasing his beneficial ownership to 33,435 shares.

Summary

• Ramin Sayar, a Director of Phreesia, Inc. (PHR), acquired 6,700 shares of common stock on June 25, 2025.
• These shares are Restricted Stock Units (RSUs) issued under the Phreesia, Inc. 2019 Stock Option and Incentive Plan.
• Each RSU represents the contingent right to receive one share of the Issuer's common stock.
• The RSUs were valued at $27.61 per share at the time of the transaction.
• Following this transaction, Mr. Sayar's direct beneficial ownership of Phreesia common stock increased to 33,435 shares.
• The RSUs are set to vest in full upon the earlier of June 25, 2026, or the next annual meeting of Phreesia's stockholders.
• The filing was signed by Allison Hoffman, acting as attorney-in-fact for Ramin Sayar, under a Power of Attorney dated January 12, 2021.
• A Substitute Power of Attorney, effective June 23, 2025, appoints Autumn Simpson as a substitute attorney-in-fact for various Phreesia officers and directors, including Ramin Sayar, to file SEC documents.

Sentiment

Score: 7

Explanation: The document reports a standard RSU grant to a director, which is generally a positive sign of aligning management interests with shareholders, but it does not contain information that would significantly alter the company's fundamental outlook or financial performance.

Positives

• Grant of Restricted Stock Units to a director aligns the director's interests with long-term shareholder value.
• The vesting schedule encourages continued commitment from the director.

Future Outlook

The vesting schedule for the granted RSUs indicates a future milestone for Ramin Sayar's compensation, with full vesting expected by June 25, 2026, or the next annual stockholders' meeting, aligning his incentives with the company's future performance.

Industry Context

This Form 4 filing is a routine disclosure of an insider stock transaction, common in publicly traded companies. The grant of Restricted Stock Units is a standard compensation practice aimed at retaining and incentivizing directors by aligning their interests with long-term shareholder value, a trend widely observed across various industries, particularly in technology and healthcare sectors like Phreesia's.

Comparison to Industry Standards

• The grant of Restricted Stock Units (RSUs) to a director is a common and widely accepted practice in corporate governance and executive compensation across industries.
• While specific comparable companies or projects are not mentioned in the filing, RSU grants are generally favored over stock options in many sectors, including healthcare technology, as they provide value even if the stock price does not significantly increase, thus offering a more predictable incentive.
• The vesting period, tied to either a specific date (June 25, 2026) or the next annual meeting, is also a standard mechanism to ensure continued service and alignment of interests, consistent with practices seen in companies like Veeva Systems (VEEV) or Cerner (CERN) (now Oracle Health) which also utilize equity-based compensation for their leadership.

Corporate Governance

Stakeholder Impact

• Shareholders: The RSU grant aligns the director's long-term interests with shareholder value, potentially leading to more stable and growth-oriented decision-making.

Next Steps

• Vesting of the 6,700 RSUs upon the earlier of June 25, 2026, or the next annual meeting of Phreesia's stockholders.

Key Dates

Recommendation

Keywords

Phreesia, PHR, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU, Director Compensation, Stock Option Plan, Beneficial Ownership, Ramin Sayar